Larvol Delta - Annovis-Bio-Completes-Dosing-of-Parkinsons-Disease-Patients-with-ANVS401-in-Phase-2a-Clinical-Trial

Posiphen (R-phenserine) - Annovis Bio

https://finance.yahoo.com/news/annovis-bio-completes-dosing-parkinsons-123000136.html

Aug 11, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next